Merck & Co., Inc. (FRA:6MK)
Germany
· Delayed Price · Currency is EUR | Market Cap | 181.62B |
| Revenue (ttm) | 59.14B |
| Net Income (ttm) | 16.13B |
| Shares Out | n/a |
| EPS (ttm) | 6.36 |
| PE Ratio | 11.26 |
| Forward PE | 8.92 |
| Dividend | 2.93 (4.25%) |
| Ex-Dividend Date | Mar 17, 2025 |
| Volume | 472 |
| Average Volume | 8,123 |
| Open | 72.00 |
| Previous Close | 71.50 |
| Day's Range | 68.80 - 72.30 |
| 52-Week Range | 66.40 - 125.60 |
| Beta | n/a |
| RSI | 44.29 |
| Earnings Date | Apr 24, 2025 |
About Merck & Co.
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janu... [Read more]
Financial Performance
In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.
Financial numbers in USD Financial StatementsNews
Pressure is still on the pharma sector, says Mizuho's Jared Holz
Jared Holz, Mizuho, joins 'Fast Money' to talk headwinds to the pharma sector.
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks
As the drug industry is in the middle of a growing policy maelstrom in Washington, D.C., investors are closely watching pharmaceutical ETFs to measure market sentiment and ride out the emerging volati...
Tesla and Google surge as healthcare sector falters in mixed market
Today's Market Overview The US stock market presents a mixed picture today, with notable performances in the consumer cyclical and communication services sectors. Giants like Tesla and Google are emer...
Merck boosts U.S. investments with $895M expansion in Kansas site
Merck Animal Health announces $895 million investment in Kansas
Merck Animal Health, a unit of Merck , said on Thursday it would invest $895 million to expand its manufacturing facility in De Soto, Kansas.
Merck Animal Health and State of Kansas Announce $895 Million Investment in Manufacturing and Research & Development Facilities in De Soto
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK), and Kansas Governor Laura Kelly jointly announc...
Merck Animal Health and State of Kansas Announce $895 Million Investment in Manufacturing and Research & Development Facilities in De Soto
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK), and Kansas Gover...
Marjorie Taylor Greene Goes Stock Shopping Again: Here Are 50+ Stocks The Congresswoman Bought
Rep. Marjorie Taylor Greene (R-Ga.) has been actively buying stocks in 2025, including transactions that may have been perfectly timed during a market dip. Here's the latest transactions made by the c...
Merck to Participate in the Bank of America 2025 Global Healthcare Conference
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Jannie Oosthuizen, president, Human Health U.S., and Dr. Marjorie Green, senior vice president and head of...
Merck to Participate in the Bank of America 2025 Global Healthcare Conference
RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Participate in the Bank of America 2025 Global Healthcare Conference.
HALOZYME RAISES 2025 FINANCIAL GUIDANCE RANGES AND REPORTS STRONG FIRST QUARTER 2025 RESULTS
Announcing New $250M Share Repurchase Total Revenue Increased 35% YOY to $265 million and Royalty Revenue Increased 39% YOY to $168 million Net Income Increased 54% YOY to $118 million ; Adjusted EBIT...
Pharma imports to US surged in March as drugmakers look to avoid tariffs
Pharmaceutical imports to the U.S. surged in March as drugmakers stocked up ahead of potential U.S. tariffs on their products, which have historically been exempt from such fees.
Why A Short Strangle Trade Might Be Best For Volatile Stocks Like Merck
Merck stock is showing high implied volatility. Option traders can take advantage of that by selling a what is called a "short strangle."
Ahead of Hong Kong IPO, China drug maker Hengrui touts partnership with US giant Merck
China’s Hengrui Pharmaceuticals seeks a path to growth as its pipeline of novel drugs expands.
Merck & Co Unusual Options Activity
Investors with a lot of money to spend have taken a bullish stance on Merck & Co (NYSE: MRK). And retail traders should know. We noticed this today when the trades showed up on publicly available opt...
Notable healthcare headlines for the week: Gilead, CVS Health, Sanofi in focus
Stay updated on top pharmaceutical news: Merck's $3.9B SpringWorks deal, Hims & Hers' Wegovy partnership, CVS exiting Obamacare, and FDA updates on key drugs.
Pharmaceutical giant details plan to create thousands of US jobs
Merck CEO Robert Davis joins 'Mornings with Maria' to discuss the new $1 billion biologics manufacturing facility slated to be built in Wilmington, Delaware, and bringing manufacturing back to the U.S...
Dogs Of The Dow Chase May's 'Safer' Buy
Verizon is the only Dow Dog meeting the ideal of annual dividends from $1K invested exceeding the single share price, supported by adequate free cash flow. Analyst projections suggest top Dow Dogs cou...
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (May 2025)
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filter...
Top 10 High-Yield Dividend Stocks To Consider In May 2025
Q2 2025 began with market volatility due to tariff announcements, resulting in SPY losing 0.87% and VYM declining by 3.54%. Since inception, my watchlist has a CAGR of 14.61%, outperforming SPY and VY...
Kuehn Law Encourages Investors of Merck & Co., Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - May 1, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Merck & Co., Inc. (NYSE: MRK) breach...
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump's pharma tariffs loom
Tariff threats are fueling a new wave of U.S. manufacturing investments from the pharmaceutical industry.
Should Investors Buy Merck Stock After These Huge Risks?
3 Names I Picked Up In The Latest Market Slump
When the market is reaching toward all-time highs, I tend to start building a cash pile. When the market starts to get quite volatile and brings declines, that can create opportunities for putting som...
Merck to invest $1B in new US plant to make blockbuster cancer treatment Keytruda
The new facility will produce biologic drugs and Keytruda, becoming Merck's first in-house US site to make the blockbuster cancer treatment, the company said.